RecruitingNCT03188874

Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

Sponsor

Technische Universität Dresden

Enrollment

15,000 participants

Start Date

Sep 1, 2010

Study Type

OBSERVATIONAL

Conditions

Acute Myeloid Leukemia (AML)

Summary

This is a registry study in adult patients with newly diagnosed or refractory/relapsed acute myeloid leukemia. Investigator's sites: 60 sites in Germany. Primary objectives: * Identification of epidemiological data on AML: age, prognostic factors and subgroup distributions. Incidence and age distribution are compared with the data of population-related tumor registry. * Evaluation of the most important patient-relevant clinical endpoints (outcomes): relapse-free survival (RFS) / time to relapse (TTR), calculation of cumulative incidence of relapse (CIR) and overall survival (OS) * Documentation of treatment strategy

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry and tissue bank study collecting medical information and biological samples from patients with acute myeloid leukemia (AML) — a fast-growing cancer of blood-forming cells in the bone marrow — to help researchers better understand and treat this disease. **You may be eligible if...** - You are 18 years or older (there is no upper age limit) - You have been diagnosed with AML (including a subtype called acute promyelocytic leukemia) based on standard medical criteria - You are willing to sign a consent form **You may NOT be eligible if...** - There are no exclusion criteria — all eligible patients who consent may join Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(60)

Klinikum Mittelbaden

Baden-Baden, Baden-Wurttemberg, Germany

Universtitätsklinikum Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

Klinikum Mannheim GmbH

Mannheim, Baden-Wurttemberg, Germany

Diakonie-Klinikum

Schwäbisch Hall, Baden-Wurttemberg, Germany

Kliniken Sindelfingen-Böblingen gGmbH

Sindelfingen, Baden-Wurttemberg, Germany

Robert-Bosch-Krankenhaus GmbH

Stuttgart, Baden-Wurttemberg, Germany

Rems-Murr-Klinikum Winnenden

Winnenden, Baden-Wurttemberg, Germany

Klinikum Augsburg

Augsburg, Bavaria, Germany

Sozialstiftung Bamberg

Bamberg, Bavaria, Germany

Klinikum Bayreuth GmbH

Bayreuth, Bavaria, Germany

MVZ Klinikum Coburg GmbH

Coburg, Bavaria, Germany

ONKO Medeor Onkologische Zentren

Donauwörth, Bavaria, Germany

Universitätsklinikum Erlangen

Erlangen, Bavaria, Germany

Klinikum Nürnberg

Nuremberg, Bavaria, Germany

Universitätsklinikum Würzburg

Würzburg, Bavaria, Germany

Carl-Thiem-Klinikum Cottbus gGmbH

Cottbus, Brandenburg, Germany

Klinikum Frankfurt (Oder) GmbH

Frankfurt (Oder), Brandenburg, Germany

Universitätsklinikum Frankfurt

Frankfurt am Main, Hesse, Germany

Klinikum Fulda / MVZ Osthessen GmbH

Fulda, Hesse, Germany

Universitätsklinikum Gießen und Marburg

Marburg, Hesse, Germany

Dr. Horst Schmidt Kliniken GmbH

Wiesbaden, Hesse, Germany

St. Bernward Krankenhaus Hildesheim

Hildesheim, Lower Saxony, Germany

Agaplesion Diakonieklinikum Rotenburg

Rotenburg (Wümme), Lower Saxony, Germany

Klinikum Wolfsburg

Wolfsburg, Lower Saxony, Germany

Diakonie Klinikum Dietrich Bonhoeffer

Neubrandenburg, Mecklenburg-Vorpommern, Germany

Klinikum Südstadt Rostock

Rostock, Mecklenburg-Vorpommern, Germany

HELIOS Klinikum Schwerin

Schwerin, Mecklenburg-Vorpommern, Germany

Marien Kliniken, St. Marien-Krankenhaus

Siegen, Nordhein-Westfalen, Germany

Universitätsklinikum Aachen

Aachen, North Rhine-Westphalia, Germany

Städt. Kliniken Bielefeld gem. GmbH - Klinikum Mitte

Bielefeld, North Rhine-Westphalia, Germany

Augusta Kranken Anstalt Bochum

Bochum, North Rhine-Westphalia, Germany

Klinikum der Universität zu Köln

Cologne, North Rhine-Westphalia, Germany

Helios Klinikum Duisburg

Duisburg, North Rhine-Westphalia, Germany

Helios Klinikum Duisburg

Duisburg, North Rhine-Westphalia, Germany

Krankenhaus Düren gGmbH

Düren, North Rhine-Westphalia, Germany

Universitätsklinikum Düsseldorf

Düsseldorf, North Rhine-Westphalia, Germany

Alfried Krupp Krankenhaus Rüttenscheid

Essen, North Rhine-Westphalia, Germany

Universitätsklinikum Essen

Essen, North Rhine-Westphalia, Germany

Klinikum Gütersloh

Gütersloh, North Rhine-Westphalia, Germany

St. Barbara-Klinik Hamm GmbH

Hamm, North Rhine-Westphalia, Germany

Universitätsklinikum Münster

Münster, North Rhine-Westphalia, Germany

Diakonie Klinikum GmbH Jung-Stilling-Krankenhaus

Siegen, North Rhine-Westphalia, Germany

Stiftungsklinikum Mittelrhein GmbH

Koblenz, Rhineland-Palatinate, Germany

Klinikum Chemnitz gGmbH

Chemnitz, Saxony, Germany

Universitätsklinikum Carl Gustav Carus

Dresden, Saxony, Germany

Universitätsklinikum Leipzig

Leipzig, Saxony, Germany

Klinikum St. Georg gGmbH

Leipzig, Saxony, Germany

Elblandkliniken Stiftung & Co.KG

Riesa, Saxony, Germany

Heinrich-Braun-Klinikum gGmbH

Zwickau, Saxony, Germany

Krankenhaus Martha-Maria Halle-Dölau

Halle, Saxony-Anhalt, Germany

Universitätsklinikum Halle (Saale)

Halle, Saxony-Anhalt, Germany

Johanniter-Krankenhaus Genthin-Stendal

Stendal, Saxony-Anhalt, Germany

Universitätsklinikum Schleswig-Holstein

Kiel, Schleswig-Holstein, Germany

Städtisches Krankenhaus Kiel GmbH

Kiel, Schleswig-Holstein, Germany

Alexianer St. Hedwig-Krankenhaus

Berlin, State of Berlin, Germany

Helios Klinikum Berlin-Buch

Berlin, State of Berlin, Germany

Klinikum Altenburger Land GmbH

Altenburg, Thuringia, Germany

Helios Klinikum Erfurt

Erfurt, Thuringia, Germany

Universitätsklinikum Jena

Jena, Thuringia, Germany

Ev. Diakonie-Krankenhaus gemeinn. GmbH Bremen

Bremen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03188874

Related Trials

Ivosidenib as Post-HSCT Maintenance for AML

NCT067074934 locations

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

NCT068112331 location

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

NCT075377381 location

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

NCT075328242 locations

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

NCT0700731239 locations